Truist Securities Reiterates Buy Rating on Evolent Health (EVH)

September 30, 2024 6:07 AM

Truist Securities analyst Jailendra Singh reiterated a Buy rating and $33.00 price target on Evolent Health (NYSE: EVH).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found